FEATURED PROMOTIONS - JAN MARINI SPRING INTO SPRING

Unbeatable Skin and Eyelash Transformations Await!
Marini Lash™, Marini Mascara™, and Age Intervention® Prime in an attractive lavender-colored gift bag signal the arrival of Spring. These three products, combined with this amazing promotional opportunity, will give you radiant skin with an airbrushed appearance, beautifully enhanced and full looking eyelashes, and a tremendous value to act on now!

Three premier products in an elegant package to Spring Into Spring! Retail pricing on gift bags during promotion *$199 . . . a savings of over $100.

*Promotion valid while quantities last.

Lumigan vs Latisse - Eyelash Enhancement

Q. What is the difference between Lumigan and Latisse?

A. Lumigan (bimatoprost ophthalmic solution 0.03%) is formulated as an eyedrop to treat glaucoma and ocular hypertension. The unexpected side effect of Lumigan is the sudden growth and thickening of the eyelashes. Once this side effect was discovered and researched, Latisse was created to be specifically used for eyelash growth. Latisse is not an eyedrop but is carefully applied to the base of the eyelash. Allergan manufactures Latisse and Lumigan. Both are each categorized as a drug and require prescriptions. Lumigan is considered "off label" and is less expensive than Latisse. It is reported they are the same product, although some say Latisse is a more diluted formulation. Lumigan is not approved by the FDA for cosmetic purposes. Clinical data clearly shows Lumigan and Latisse grow eye-popping, thick and lustrous eyelashes. B-l-i-n-k!

Note: Email us for more information on Lumigan or Latisse and we will forward a link to an in-depth forum on the topic.

Latisse - Eyelash Enhancement

Long, lustrous eyelashes. Allergan, the company that manufactures Botox, received approval from the FDA to market an eyelash growth drug, Latisse, at the beginning of this year. The active ingredient, bimatoprost ophthalmic solution 0.03, was initially used to treat glaucoma. During trials, it was found to have a positive side effect that increased the amount of hair in the lash as well as keeping the hair in a prolonged growth phrase. This was great news for those who have sparse eyelashes related to a condition called hypotrichosis, or for those who have lost their lashes due to chemotherapy. Since then, thousands of women have attested to the success of this product and are sporting long and lustrous lashes.

Since it is classified as a drug, Latisse is only available through a doctor's prescription. The product comes in a mascara tube and is applied once daily to the base of the upper lashes with a one-time use sterile, disposable applicator. It is not to be used on the lower lashes. In as little as 4 weeks, throughout a full course of 16 weeks, the lashes are expected to be longer, thicker and darker.

The cost? Approximately $120 for a 30 day supply. Save your pennies . . . the eyelash enhancing properties of Latisse is not permanent. The minute you stop using the product your lashes will return to the length and condition they were before the treatment began. There are reports of a small risk to an irreversible brown spots within the iris of the eyes for those with blue or light colored eyes. There have also been reports of the darkening of the eyelid skin, which will disappear once the product is no longer used. Other common side effects are itchy eyes in approximately 4% of users, redness around the eyelids, and dry eyes.